Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT01560000
First received: March 5, 2012
Last updated: March 13, 2013
Last verified: March 2013
  Purpose

The objective of this study is to determine the satiety value of different bran fibers on appetite & subsequent food intake with acute consumption. Satiety will be measured subjectively by visual analogue scales (VAS).


Condition Intervention
Food
Dietary Supplement: Dietary fiber

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention
Official Title: Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite

Resource links provided by NLM:


Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:
  • Satiety response [ Time Frame: 4 hours ] [ Designated as safety issue: No ]

Enrollment: 40
Study Start Date: March 2012
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
fiber Dietary Supplement: Dietary fiber
Wheat, barley, oat and bran fibers added to a breakfast product

Detailed Description:

Visual analogue scales will be used to measure satiety at 15, 30 45, 60, 120, 180, and 240 minutes

  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy women between the ages of 18-40
  • body mass index between 18.5-29.9kg/m2
  • eat breakfast regularly
  • nonsmoking
  • not taking weight loss medications
  • non-dieting (weight stable over the past 3 months)
  • spoken and written English literacy.

Exclusion Criteria:

  • antibiotic use within the past 6 months
  • cardiovascular disease
  • diabetes mellitus
  • cancer in the past 5 years
  • renal or hepatic disease
  • recent bacterial infection
  • gastrointestinal conditions affecting digestion or absorption
  • weight loss>5kg in prior 3 months (intentional or unintentional)
  • history of drug or alcohol abuse in prior 6 months
  • food allergies
  • high fiber intake(3 or more servings of high fiber foods per day)
  • lipid-lowering, anti-hypertensive or anti-inflammatory steroid medication use
  • restrained eater(score>10 on the dietary restraint factor of the Three Factor Eating Questionnaire)
  • concurrent or recent (within 30 days) participation in an intervention study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01560000

Locations
United States, Minnesota
University of Minnesota
Saint Paul, Minnesota, United States, 55108
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: Joanne Slavin, PhD University of Minnesota - Clinical and Translational Science Institute
  More Information

No publications provided by University of Minnesota - Clinical and Translational Science Institute

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier: NCT01560000     History of Changes
Other Study ID Numbers: 1202E10321
Study First Received: March 5, 2012
Last Updated: March 13, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
The focus of this study is to determine satiety

ClinicalTrials.gov processed this record on September 18, 2014